Bristol-Myers Squibb Company (BMY) (JOBS) Enters Global Collaboration with Nissan Chemical Industries, Ltd. and Teijin Pharma on Novel Atrial Fibrillation Compound; Bristol to Pay $40 Million for Heart Drug
3/5/2009 7:46:47 AM
More...
|
Indigo Pharmaceuticals, Inc. Signs License Agreement for INDI-702, a Drug for the Treatment of Arteriosclerosis Obliterans, With Nissan Chemical Industries, Ltd. and Taisho Pharmaceutical
6/1/2007 11:07:44 AM
More...
|
Nissan Chemical Industries, Ltd. Reports Positive Phase IIb Study Results For NM-702 In Intermittent Claudication
3/13/2006 11:16:37 AM
More...
|
Nissan Chemical Industries, Ltd., Teijin Pharma To Collaborate In Developing Drug Candidate For Atrial Fibrillation And Flutter
10/19/2005 5:09:07 PM
More...
|